Evolution of Radionuclide Therapy in Prostate Cancer
Type
Webinaire
DÉTAILS DE L’ACTIVITÉ
Display Date
Tuesday November 26 2024
Display Date Line 2
19:00 pm ET
Location
Virtual
Speaker
Neil Fleshner & Sebastien Hotte
CRÉDITS
Accreditation
Section 1 Group Learning Credits
Event Description
Speakers: Neil Fleshner & Sebastien Hotte
Objectives
By participating in this learning program, healthcare providers can expect to gain an understanding of:
- Understand the current role of radionuclide therapy in managing prostate cancer patients and discuss strategies for sequencing
- Explore the latest clinical data on radionuclide therapies in prostate cancer including emerging treatment strategies
- Discuss the future direction of radionuclide therapy in prostate cancer, including the development of next-generation molecules and combination therapies
Footer
ACCREDITATION
This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
_______________________________________________________________________
Sponsor:
